186 related articles for article (PubMed ID: 7473242)
21. Lambert-Eaton antibodies inhibit Ca2+ currents but paradoxically increase exocytosis during stimulus trains in bovine adrenal chromaffin cells.
Engisch KL; Rich MM; Cook N; Nowycky MC
J Neurosci; 1999 May; 19(9):3384-95. PubMed ID: 10212298
[TBL] [Abstract][Full Text] [Related]
22. Electrophysiological diagnostic criteria of Lambert-Eaton myasthenic syndrome.
Oh SJ; Kurokawa K; Claussen GC; Ryan HF
Muscle Nerve; 2005 Oct; 32(4):515-20. PubMed ID: 16003742
[TBL] [Abstract][Full Text] [Related]
23. Is the decremental pattern in Lambert-Eaton syndrome different from that in myasthenia gravis?
Sanders DB; Cao L; Massey JM; Juel VC; Hobson-Webb L; Guptill JT
Clin Neurophysiol; 2014 Jun; 125(6):1274-7. PubMed ID: 24332471
[TBL] [Abstract][Full Text] [Related]
24. Specificity of omega-conotoxin MVIIC-binding and -blocking calcium channel antibodies in Lambert-Eaton myasthenic syndrome.
Nakao YK; Motomura M; Suenaga A; Nakamura T; Yoshimura T; Tsujihata M; Mori M; Itoh M; Nagataki S
J Neurol; 1999 Jan; 246(1):38-44. PubMed ID: 9987712
[TBL] [Abstract][Full Text] [Related]
25. Single motor end-plates in myasthenia gravis and LEMS at different firing rates.
Trontelj JV; Stålberg E
Muscle Nerve; 1991 Mar; 14(3):226-32. PubMed ID: 1645844
[TBL] [Abstract][Full Text] [Related]
26. Disruption of synaptosomal calcium channel function by Lambert-Eaton myasthenic immunoglobulin is serum-dependent.
Hewett SJ; Atchison WD
Brain Res; 1992 Dec; 599(2):317-23. PubMed ID: 1363288
[TBL] [Abstract][Full Text] [Related]
27. Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma.
Meriney SD; Hulsizer SC; Lennon VA; Grinnell AD
Ann Neurol; 1996 Nov; 40(5):739-49. PubMed ID: 8957015
[TBL] [Abstract][Full Text] [Related]
28. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
Takamori M
J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of low- and high-threshold Ca2+ channels of human neuroblastoma IMR32 cells by Lambert-Eaton myasthenic syndrome (LEMS) IgGs.
Grassi C; Magnelli V; Carabelli V; Sher E; Carbone E
Neurosci Lett; 1994 Nov; 181(1-2):50-6. PubMed ID: 7898770
[TBL] [Abstract][Full Text] [Related]
30. Serum and plasma from patients with Lambert-Eaton Myasthenic Syndrome reduce depolarization-dependent uptake of 45Ca2+ into rat cortical synaptosomes.
Hewett SJ; Atchison WD
Brain Res; 1991 Dec; 566(1-2):320-4. PubMed ID: 1814548
[TBL] [Abstract][Full Text] [Related]
31. Modelling the response to low-frequency repetitive nerve stimulation of myasthenia gravis and Lambert-Eaton myasthenic syndrome.
Miralles F
Med Biol Eng Comput; 2016 Nov; 54(11):1761-1778. PubMed ID: 27016366
[TBL] [Abstract][Full Text] [Related]
32. Lambert-Eaton myasthenic syndrome presenting with severe respiratory failure.
Nicolle MW; Stewart DJ; Remtulla H; Chen R; Bolton CF
Muscle Nerve; 1996 Oct; 19(10):1328-33. PubMed ID: 8808659
[TBL] [Abstract][Full Text] [Related]
33. The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen.
Leveque C; Hoshino T; David P; Shoji-Kasai Y; Leys K; Omori A; Lang B; el Far O; Sato K; Martin-Moutot N
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3625-9. PubMed ID: 1314395
[TBL] [Abstract][Full Text] [Related]
34. Repetitive nerve stimulation and single-fiber electromyography in the evaluation of patients with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: Review of recent literature.
Chiou-Tan FY; Gilchrist JM
Muscle Nerve; 2015 Sep; 52(3):455-62. PubMed ID: 26109387
[TBL] [Abstract][Full Text] [Related]
35. Decrement pattern in Lambert-Eaton myasthenic syndrome is different from myasthenia gravis.
Baslo MB; Deymeer F; Serdaroglu P; Parman Y; Ozdemir C; Cuttini M
Neuromuscul Disord; 2006 Jul; 16(7):454-8. PubMed ID: 16806929
[TBL] [Abstract][Full Text] [Related]
36. Presynaptic effects of immunoglobulin G from patients with Lambert-Eaton myasthenic syndrome: their neutralization by intravenous immunoglobulins.
Buchwald B; Ahangari R; Weishaupt A; Toyka KV
Muscle Nerve; 2005 Apr; 31(4):487-94. PubMed ID: 15685615
[TBL] [Abstract][Full Text] [Related]
37. [Decrement pattern of M-response amplitude in the low-frequency repetitive nerve stimulation in the muscles of patients with myasthenia gravis and Lambert-Eaton myasthenic syndrome].
Tumurov DA; Sanadze AG
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2):93-96. PubMed ID: 28374700
[TBL] [Abstract][Full Text] [Related]
38. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
Andreis I; Lovnićki TJ; Beara N; Taradi M
Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
[TBL] [Abstract][Full Text] [Related]
39. Functional evaluation of inhibition of autonomic transmitter release by autoantibody from Lambert-Eaton myasthenic syndrome.
Houzen H; Hattori Y; Kanno M; Kikuchi S; Tashiro K; Motomura M; Nakao Y; Nakamura T
Ann Neurol; 1998 May; 43(5):677-80. PubMed ID: 9585366
[TBL] [Abstract][Full Text] [Related]
40. Ocular LEMS or MLOS.
Rattananan W; Alsharabati M; Oh SJ
Muscle Nerve; 2016 Nov; 54(5):981-982. PubMed ID: 27177846
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
